A Randomised Trial of EECP for the treatment of subclinical atherosclerosis

Efffect of EECP on subclinical atherosclerosis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001705

Enrollment

Unknown

Registered

2010-04-22

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Interventions

One:Simvastatin 40 mg qd

EECP treatment, one course (35-36 h)

Two:Simvastatin 40 mg qd

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: LDL higher than 4.14 mmol/L, IMT higher than 75 percent of age

Exclusion criteria

Exclusion criteria: Clinical coronary artey disease

Design outcomes

Primary

Measure	Time frame
IMT;	—

Countries

China

Contacts

Public ContactYan Zhang

zhyan3@mail.sysu.edu.cn+86 13711234160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026